drugset / Trial / NCT05417425
Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers
NaSingle-groupOpen-labelTreatment
Summary
This study is to evaluate the efficacy of OCM™ used in combination with off-loading devices for the treatment of diabetic foot ulcers.
Timeline
- Start
- 2022-09-01
- Primary completion
- 2023-10-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | — | Topical |
| Subject | Omeza skin protectant | Unknown | — | Topical |